Intuitive gets FDA nod for da Vinci SP system for simple prostatectomy
Iryna Drozd

The U.S. Food and Drug Administration cleared Intuitive Surgical's (NASDAQ:ISRG) da Vinci SP surgical system for simple prostatectomy as a representative procedure.
In Simple Prostatectomy is surgery to remove part of the prostate which has become big and is causing issues such as blocking flow of urine.

The FDA also cleared the da Vinci SP surgical system for transvesical approach to simple and radical prostatectomy using the da Vinci SP.
In radical prostatectomy the entire prostate gland is removed, usually in patients with prostate cancer.
"The addition of simple prostatectomy and the transvesical approach to prostatectomy to the da Vinci SP clearances expands the existing urology indication for SP," said Myriam Curet, chief medical officer of Intuitive.